v3.19.1
23. Share-based Compensation (Tables)
|
12 Months Ended |
|
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] |
|
Summary of consolidated stock-based compensation expense, by type of awards |
| |
For the Years Ended | |
| |
December 31, | | |
December 31, | | |
December 31, | |
| |
2018 | | |
2017 | | |
2016 | |
Employee stock options | |
$ | 1,799 | | |
$ | 886 | | |
$ | 962 | |
Restricted stock grants | |
| 927 | | |
| 288 | | |
| 339 | |
Total share-based compensation
expense | |
$ | 2,726 | | |
$ | 1,174 | | |
$ | 1,301 | |
|
Summary of consolidated stock-based compensation by line items |
| |
For the Years Ended | |
| |
December
31, 2018 | | |
December
31, 2017 | | |
December
31,
2016 | |
General and administrative | |
$ | 2,579 | | |
$ | 1,131 | | |
$ | 1,274 | |
Sales, marketing and customer
service | |
| 147 | | |
| 43 | | |
| 27 | |
Total share-based compensation
expense | |
| 2,726 | | |
| 1,174 | | |
| 1,301 | |
Total share-based compensation
expense after income taxes | |
$ | 2,726 | | |
$ | 1,174 | | |
$ | 1,301 | |
|
Summary of assumptions used in the determination of the fair value of share-based payment awards using the Black-Scholes model for stock option grants |
Assumptions used in the determination
of the fair value of share-based payment awards using the Black-Scholes model for stock option grants were as follows:
|
|
For the Years Ended |
|
|
|
December 31,
2018 |
|
|
December 31,
2017 |
|
|
December 31,
2016 |
|
Expected term |
|
|
6.25 |
|
|
|
6.25 |
|
|
|
4 |
|
Risk-free interest rate |
|
|
2.54%-3.03% |
|
|
|
1.81%-2.30% |
|
|
|
1.15% - 2.26% |
|
Expected volatility |
|
|
624%-756% |
|
|
|
284%-763% |
|
|
|
166% - 178% |
|
Expected dividend yield |
|
|
0% |
|
|
|
0% |
|
|
|
0% |
|
|
Summary of stock option activities |
| |
Shares | | |
Weighted-Average Exercise Price
Per Share | | |
Weighted-Average Remaining
Contractual Term | | |
Aggregate Intrinsic Value ($000) | |
Outstanding as of December 31, 2015 | |
| 635,488 | | |
| 145 | | |
| 7.85 | | |
$ | 87,401 | |
Granted | |
| 268,490 | | |
| 47 | | |
| | | |
| | |
Exercised | |
| (1,000 | ) | |
| 49 | | |
| | | |
| | |
Forfeited/expired | |
| (352,218 | ) | |
| 169 | | |
| | | |
| | |
Outstanding as of December 31, 2016 | |
| 550,760 | | |
| 82 | | |
| 7.40 | | |
$ | 60,032 | |
Granted | |
| 325,300 | | |
| 4 | | |
| | | |
| | |
Exercised | |
| – | | |
| – | | |
| | | |
| | |
Forfeited/expired | |
| (374,800 | ) | |
| 36 | | |
| | | |
| | |
Outstanding as of December 31, 2017 | |
| 501,260 | | |
| 66 | | |
| 7.03 | | |
$ | 769 | |
Granted | |
| 287,000 | | |
| 13 | | |
| | | |
| | |
Exercised | |
| – | | |
| – | | |
| | | |
| | |
Forfeited/expired | |
| (528,060 | ) | |
| 10 | | |
| | | |
| | |
Outstanding as of December 31, 2018 | |
| 260,200 | | |
| 212 | | |
| 8.59 | | |
$ | – | |
Vested and exercisable as of December 31, 2018 | |
| 76,900 | | |
| 29 | | |
| 9.12 | | |
$ | – | |
Expected to vest as of December 31, 2018 | |
| 177,383 | | |
| 12 | | |
| 8.29 | | |
$ | – | |
|
Summary of exercise price and remaining life information about options exercisable |
Range of exercise price | |
Shares Exercisable | | |
Weighted Average Remaining Contractual
Life | | |
Weighted Average
Exercise Price | | |
Aggregate Intrinsic ($000) | |
$118 - $172 | |
| 750 | | |
| 7.13 | | |
| 172 | | |
| – | |
$40 - $117 | |
| 28,200 | | |
| 8.39 | | |
| 64 | | |
| – | |
$2 - $39 | |
| 47,950 | | |
| 9.58 | | |
| 6 | | |
| – | |
| |
| 76,900 | | |
| | | |
| | | |
| – | |
|
Summary of changes in non-vested stock awards |
| |
Time-based Options | | |
Restricted Stock | |
| |
Shares | | |
Weighted Average Exercise Price
Per Share | | |
Shares | | |
Weighted Average Grant-Date
Fair Value Per Share | |
Non-vested as of December 31, 2015 | |
| 559,658 | | |
$ | 128 | | |
| 8,778 | | |
$ | 178 | |
Granted | |
| 268,491 | | |
| 47 | | |
| – | | |
| – | |
Vested | |
| (45,573 | ) | |
| 110 | | |
| (2,778 | ) | |
| 178 | |
Forfeited | |
| (352,218 | ) | |
| 169 | | |
| (1,250 | ) | |
| 177 | |
Non-vested as of December 31, 2016 | |
| 430,358 | | |
$ | 46 | | |
| 4,750 | | |
$ | 178 | |
Granted | |
| 325,300 | | |
| 4 | | |
| – | | |
| – | |
Vested | |
| (100,663 | ) | |
| 43 | | |
| (2,187 | ) | |
| 128 | |
Forfeited | |
| (275,075 | ) | |
| 48 | | |
| (1,250 | ) | |
| 177 | |
Non-vested as of December 31, 2017 | |
| 379,920 | | |
$ | 9 | | |
| 1,313 | | |
$ | 264 | |
Granted | |
| 287,000 | | |
| 13 | | |
| 663,460 | | |
| 1 | |
Vested | |
| (87,285 | ) | |
| 25 | | |
| (663,273 | ) | |
| 1 | |
Forfeited | |
| (396,335 | ) | |
| 13 | | |
| (250 | ) | |
| 185 | |
Non-vested as of December 31, 2018 | |
| 183,300 | | |
$ | 8 | | |
| 1,250 | | |
$ | 185 | |
|
Summary of restricted stock awards |
| |
Number of Shares | | |
Weighted Average Grant-Date Fair Value | |
Restricted stock units at December 31, 2015 | |
| 218,309 | | |
| 151 | |
Granted | |
| – | | |
| – | |
Forfeited | |
| (1,250 | ) | |
| 177 | |
Restricted stock units at December 31, 2016 | |
| 217,059 | | |
| 151 | |
Granted | |
| – | | |
| – | |
Forfeited | |
| (1,250 | ) | |
| 177 | |
Restricted stock units at December 31, 2017 | |
| 215,809 | | |
| 151 | |
Granted | |
| 663,460 | | |
| 1 | |
Forfeited | |
| (250 | ) | |
| 185 | |
Restricted stock units at December 31, 2018 | |
| 879,019 | | |
| 38 | |
|
X |
- DefinitionTabular disclosure of components of a stock option or other award plan under which equity-based compensation is awarded to employees, typically comprised of the amount of unearned compensation (deferred compensation cost), compensation expense, and changes in the quantity and fair value of the shares (or other type of equity) granted, exercised, forfeited, and issued and outstanding pertaining to that plan. Disclosure may also include nature and general terms of such arrangements that existed during the period and potential effects of those arrangements on shareholders, effect of compensation cost arising from equity-based payment arrangements on the income statement, method of estimating the fair value of the goods or services received, or the fair value of the equity instruments granted, during the period, cash flow effects resulting from equity-based payment arrangements and, for registrants that accelerate vesting of out of the money share options, reasons for the decision to accelerate.
+ References
+ Details
Name: |
us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
nonnum:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTabular disclosure of the allocation of equity-based compensation costs to a given line item on the balance sheet and income statement for the period. This may include the reporting line for the costs and the amount capitalized and expensed.
+ References
+ Details
Name: |
us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
nonnum:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTabular disclosure of the changes in outstanding nonvested shares.
+ References
+ Details
Name: |
us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
nonnum:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.
+ References
+ Details
Name: |
us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
nonnum:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.
+ References
+ Details
Name: |
us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
nonnum:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.
+ References
+ Details
Name: |
us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
nonnum:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionDisclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.
+ References
+ Details
Name: |
us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
nonnum:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
|